Piper Sandler lowered the firm’s price target on Integral Ad Science to $18 from $20 and keeps an Overweight rating on the shares. The firm notes shares are indicated down about 20% after the company provided Q1 and 2024 guidance below expectations. To Piper, core business momentum appears to be strong, with several new product launches ramping through 2024. However, more competitive pricing dynamics for certain contract renewals in measurement are weighing on the near-term outlook.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IAS:
- IAS Reports Fourth Quarter and Full Year 2023 Financial Results
- Integral Ad expands AI-driven safety and suitability measurement to Meta
- Integral Ad Science initiated with a Buy at BofA, sees long runway for growth
- Integral Ad Science initiated with a Buy at BofA
- ‘2024 Will Be a Breakout Year for AdTech,’ According to BMO — Here Are 3 Stocks to Take Advantage
